Amyloid precursor protein, copper and Alzheimer's disease

Biomedicine and Pharmacotherapy

Volumn 51, Issue 3, 1997, Pages 105-111

  Multhaup, G ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Alzheimer's disease (AD); familial amyotrophic lateral sclerosis (FALS); hydroxyl radicals

Indexed keywords

AMYLOID PRECURSOR PROTEIN; COPPER; FREE RADICAL; HYDROGEN PEROXIDE; HYDROXYL RADICAL; OXYGEN RADICAL; SUPEROXIDE DISMUTASE;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; HUMAN; PRIORITY JOURNAL; REVIEW;

EID: 0030888868     PISSN: 07533322     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0753-3322(97)86907-7     Document Type: Article

References (73)

1. 1 Scheuner D, Eckman C, Jensen M et al. Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. Nature Med 1996;2:864-70
2. 2 Selkoe DJ. Amyloid beta-protein and the genetics of Alzheimer's disease. J Biol Chem 1996;271:18295-98
3. 3 Chartier-Harlin MC, Crawford F, Houlden H et al. Early-onset Alzheimer's disease caused by mutations at codon 717 of the β-amyloid precursor protein gene. Nature 1991;353:844-6
4. 4 Goate A, Chartier Harlin MC, Mullan M et al. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 1991;349:704-6
5. 5 Hendriks L, van Duijn CM, Cras P et al. Presenile dementia and cerebral haemorrhage linked to a mutation at codon 692 of the β-amyloid precursor protein gene. Nat Genet 1992;1:218-21
6. 6 Mullan M, Crawford F, Axelman K et al. A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N-terminus of β-amyloid. Nat Genet 1992;1:345-7
7. 7 Naruse S, Igarashi S, Kobayashi H et al. Mis-sense mutation Val - Ile in exon 17 of amyloid precursor protein gene in Japanese familial Alzheimer's disease. Lancet 1991;337:978-9
8. 8 Sherrington R, Rogaev EI, Liang Y et al. Cloning of a gene bearing missense muations in early-onset familial Alzheimer's disease. Nature 1995;375:754-60
9. 9 Slunt HH, Thinakaran G, Lee MK, Sisodia SS. Nucleotide sequence of the chromosome 14-encoded S182 cDNA and revised secondary structure prediction. Amyloid. Int J Exp Clin Invest 1995;2:188-90
10. 10 Cai XD, Golde TE, Younkin SG. Release of excess amyloid β protein from a mutant amyloid β protein precursor. Science 1993;259:514-6
11. 11 Citron M, Oltersdorf T, Hanss C et al. Mutation of the β-amyloid precursor protein in familial Alzheimer's disease increases β-protein production. Nature 1992;360:672-4
12. 12 Suzuki N, Cheung TT, Cai XD et al. An increased percentage of long amyloid β protein secreted by familial amyloid β protein precursor (bAPP717) mutants. Science 1994;264:1336-40
13. 13 Iwatsubo T, Mann DMA, Idaka A, Suzuki N, Ihara Y. Amyloid beta protein (A-beta) deposition: A-beta-42(43) precedes A-beta-40 in Down syndrome. Ann Neurol 1995;37:294-9
14. 14 Burdick D, Soreghan B, Kwon M et al. Assembly and aggregation properties of synthetic Alzheimer's A4/beta amyloid peptide analogs. J Biol Chem 1992;267:546-54
15. 15 Jarrett JT, Berger EP, Lansbury PT, Jr. The carboxy terminus of the beta amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease. Biochemistry 1993;32:4693-7 (Issn: 0006-2960)
16. 16 Jarrett JT, Lansbury PT, Jr. Seeding 'one-dimensional crystallization' of amyloid: a pathogenic mechanism in Alzheimer's disease and scrapie? Cell 1993;73:1055-8
17. 17 Iwatsubo T, Odaka A, Suzuki N, Mizusawa H, Nukina N, Ihara Y. Visualization of Ab42(43) and Ab40 in senile plaques with end-specific Ab monoclonals: evidence that an initially deposited species is Ab42(43). Neuron 1994;13:45-53
18. 18 Rumble B, Retallack R, Hilbich C et al. Amyloid A4 protein and its precursor in Down's syndrome and Alzheimer's disease. N Engl J Med 1989;320:1446-52
19. 19 Busciglio J, Gabuzda DH, Matsudaira P, Yankner BA. Generation of beta-amyloid in the secretory pathway in neuronal and non-neuronal cells. Proc Natl Acad Sci USA 1993;90:2092-6
20. 20 Haass C, Schlossmacher MG, Hung AY et al. Amyloid beta-peptide is produced by cultured cells during normal metabolism. Nature 1992;359:322-5
21. 21 Shoji M, Golde TE, Ghiso J et al. Production of the Alzheimer amyloid beta protein by normal proteolytic processing. Science 1992;258:126-9
22. 22 Kuo YM, Emmerling MR, Vigo Pelfrey C et al. Water-soluble A-beta (N-40, N-42) oligomers in normal and Alzheimer disease brains. J Biol Chem 1996;271:4077-81
23. 23 Araujo DM, Cotman CW. Beta-amyloid stimulates glial cells in vitro to produce growth factors that accumulate in senile plaques in Alzheimer's disease. Brain Res 1992;569:141-5
24. 24 Busciglio J, Yeh J, Yankner BA. Beta-amyloid neurotoxicity in human cortical culture is not mediated by excitotoxins. J Neurochem 1993;61:1565-8
25. + homeostasis and cell death. J Neurosci 1995;15:6239-49
26. 26 Mattson MP. Calcium and neuronal injury in Alzheimer's disease. Contributions of beta-amyloid precursor protein mismetabolism, free radicals, and metabolic compromise. Ann NY Acad Sci 1994;747:50-76
27. 27 Smith MA, Sayre LM, Monnier VM, Perry G. Radical ageing in Alzheimer's disease. Trends Neurosci 1995;18:172-6
28. 28 Yan SD, Chen X, Fu J et al. Receptor for advanced glycation end-products (RAGE) and amyloid-beta peptide neurotoxicity in Alzheimer's disease. Nature 1996;382:685-91
29. 29 Yankner BA. Mechanisms of neuronal degeneration in Alzheimer's disease. Neuron 1996;16:921-32
30. 30 Bush AI, Pettingell WH, Multhaup G et al. Rapid induction of Alzheimer A beta-amyloid formation by zinc. Science 1994;265:1464-7
31. 31 Mantyh PW, Ghilardi JR, Rogers S et al. Aluminum, iron, and zinc ions promote aggregation of physiological concentrations of beta-amyloid peptide. J Neurochem 1993;61:1171-4
32. 32 Dyrks T, Dyrks E, Hartmann T, Masters C, Beyreuther K. Amyloidogenicity of βA4 and βA4-bearing amyloid protein precursor fragments by metal-catalyzed oxidation. J Biol Chem 1992;267:18210-7
33. 33 Bush AI, Multhaup G, Moir RD et al. A novel zinc(II) binding site modulates the function of the beta A4 amyloid protein precursor of Alzheimer's disease. J Biol Chem 1993;268:16109-12
34. 34 Multhaup G. Identification and regulation of the high affinity binding site of the Alzheimer's disease amyloid protein precursor (APP) to glycosaminoglycans. Biochimie 1994;76:304-11
35. 35 Multhaup G, Bush AI, Pollwein P. Masters CL. Interaction between the zinc (II) and the heparin binding site of the Alzheimer's disease beta A4 amyloid precursor protein (APP). FEBS Lett 1994;355:151-4
36. 36 Komiyama Y, Murakami T, Egawa H, Okubo S, Yasunaga K, Murata K. Purification of factor XIa inhibitor from human platelets. Thromb Res 1992;66:397-408
37. 37 Van Nostrand WE. Zinc (II) selectively enhances the inhibition of coagulation factor XIa by protease nexin-2/amyloid beta-protein precursor. Thromb Res 1995;78:43-53
38. 38 Simons M, Ikonen E, Tienari PJ et al. Intracellular routing of human amyloid protein precursor: axonal delivery followed by transport to the dendrites. J Neurosci Res 1995;41:121-8
39. 39 Hesse L, Beher D, Masters CL, Multhaup G. FEBS Let. 1994;349:109-16
40. 40 Multhaup G, Schlicksupp A, Hesse L et al. The amyloid precursor protein of Alzheimer's disease in the reduction of copper(II) to copper(I). Science 1996;271:1406-9
41. 41 Sies H. Strategies of antioxidant defense. Eur J Biochem 1993;215:213-9
42. 42 Beckman JS, Beckman TW, Chen J, Marshall PA, Freeman BA. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci USA 1990;87:1620-4
43. 43 Chance B, Sies H, Boveris A. Hydroperoxide metabolism in mammalian organs. Physiol Rev 1979;59:527-605
44. 44 Fridovich I. Superoxide dismutases. Annu Rev Biochem 1975;44:147-59
45. 45 Halliwell B, Gutteridge JM. Role of free radicals and catalytic metal ions in human disease: an overview. Methods Enzymol 1990;186:1-85
46. 46 Lynch RE, Fridovich I. Permeation of the erythrocyte stroma by Superoxide radical. J Biol Chem 1978;253:4697-9
47. 47 Takahashi MA, Asada K. Superoxide anion permeability of phospholipid membranes and chloroplast thylakoids. Arch Biochem Biophys 1983;226:558-66
48. 48 Halliwell B, Gutteridge JM. Biologically relevant metal ion-dependent hydroxyl radical generation. An update. FEBS Lett 1992;307:108-12
49. 49 Smith CD, Carney JM, Starke Reed PE et al. Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer's disease. Proc Natl Acad Sci USA 1991;88:10540-3
50. 50 Busciglio J, Yankner BA. Apoptosis and increased generation of reactive oxygen species in Down's syndrome neurons in vitro. Nature 1995;378:776-9
51. 51 Stadtman, ER. Protein oxidation and aging. Science 1992;257:1220-4
52. 52 Smith MA, Perry G, Richey PL et al. Oxidative damage in Alzheimer's. Nature 1996;382:120-1
53. 53 Pacifici RE, Salo DC, Davies KJ. Macroxyproteinase (MOP): a 670 kDa proteinase complex that degrades oxidatively denatured proteins in red blood cells. Free Radic Biol Med 1989;7:521-36
54. 54 Davies KJ, Delsignore ME. Protein damage and degradation by oxygen radicals. III. Modification of secondary and tertiary structure. J Biol Chem 1987;262:9908-13
55. 55 Marcillat O, Zhang Y, Lin SW, Davies KJ. Mitochondria contain a proteolytic system which can recognize and degrade oxidatively-denatured proteins. Biochem J 1988;254:677-83
56. 56 Davies KJ, Lin SW, Pacifici RE. Protein damage and degradation by oxygen radicals. IV. Degradation of denatured protein. J Biol Chem 1987;262:9914-20
57. 57 Brown RH, Jr. Amyotrophic lateral sclerosis: recent insights from genetics and transgenic mice. Cell 1995;80:687-92
58. 58 Norton WA, Eldridge R, Brody JA. Familial motor neuron disease. Evidence for at least three different types. Neurology 1976;26:460-5
59. 59 Deng HX, Hentati A, Tainer JA et al. Amyotrophic lateral sclerosis and structural defects in Cu, Zn superoxide dismutase. Science 1993;261:1047-51
60. 60 Wong PC, Pardo CA, Borchelt DR et al. An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria. Neuron 1995;14:1105-16
61. 61 Gurney ME, Pu H, Chiu AY et al. Motor neuron degeneration in mice that express a human Cu, Zn superoxide dismutase mutation. Science 1994;264:1772-5
62. 62 Hodgson EK, Fridovich I. The interaction of bovine erythrocyte superoxide dismutase with hydrogen peroxide: inactivation of the enzyme. Biochemistry 1975;14:5294-9
63. 2 plus Cu, Zn-superoxide dismutase reflects the activity of free copper released from the oxidatively damaged enzyme. J Biol Chem 1992;267:25371-7
64. n1 for hydrogen peroxide. Proc Natl Acad Sci USA 1996;93:5709-14
65. 65 Wiedau-Pazos M, Goto JJ, Rabizadeh S et al. Altered reactivity of superoxide dismutase in familial amyotrophic lateral sclerosis. Science 1996;271:515-18
66. 66 Hesse L, Beher D, Masters CL, Multhaup G. The beta A4 amyloid precursor protein binding to copper. FEBS Lett 1994;349:109-16
67. 67 Epstein CJ, Avraham KB, Lovett M et al. Transgenic mice with increased Cu/Zn-superoxide dismutase activity: animal model of dosage effects in Down syndrome. Proc Natl Acad Sci USA 1987;84:8044-8
68. 67 Rosen DR, Siddique T, Patterson D et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 1993;362:59-62
69. 68 Fitzgerald DJ. Zinc and Alzheimer's disease. Science 1995;268:1920-3
70. 69 Hershey CO, Hershey LA, Varnes A. Vibhakar SD, Lavin P, Strain WH. Cerebrospinal fluid trace element content in dementia: clinical, radiologic, and pathologic correlations. Neurology 1983;33:1350-3
71. 70 Basun H, Forssell LG, Wetterberg L, Winblad B. Metals and trace elements in plasma and cerebrospinal fluid in normal aging and Alzheimer's disease. J Neural Transm Park Dis Dement Sect 1991;3:231-58
72. 71 Dyrks T, Dyrks E, Monning U, Urmoneit B, Turner J, Beyreuther K. Generation of beta A4 from the amyloid protein precursor and fragments thereof. FEBS Lett 1993;335:89-93
73. 72 Pike CJ, Cotman CW. Cultured GABA-immunoreactive neurons are resistant to toxicity induced by beta-amyloid. Neuroscience 1993;56:269-74